X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs TORRENT PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA TORRENT PHARMA SANOFI INDIA/
TORRENT PHARMA
 
P/E (TTM) x 32.9 29.2 112.6% View Chart
P/BV x 6.3 5.6 112.8% View Chart
Dividend Yield % 1.4 1.0 146.8%  

Financials

 SANOFI INDIA   TORRENT PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
TORRENT PHARMA
Mar-17
SANOFI INDIA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs4,5601,768 257.9%   
Low Rs4,4001,186 371.1%   
Sales per share (Unadj.) Rs1,028.5346.1 297.2%  
Earnings per share (Unadj.) Rs129.055.2 233.8%  
Cash flow per share (Unadj.) Rs186.073.3 253.7%  
Dividends per share (Unadj.) Rs68.0014.00 485.7%  
Dividend yield (eoy) %1.50.9 160.1%  
Book value per share (Unadj.) Rs753.6257.1 293.2%  
Shares outstanding (eoy) m23.03169.22 13.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.44.3 102.1%   
Avg P/E ratio x34.726.8 129.8%  
P/CF ratio (eoy) x24.120.1 119.6%  
Price / Book Value ratio x5.95.7 103.5%  
Dividend payout %52.725.4 207.8%   
Avg Mkt Cap Rs m103,174249,887 41.3%   
No. of employees `0003.611.8 30.8%   
Total wages/salary Rs m3,5929,934 36.2%   
Avg. sales/employee Rs Th6,537.74,971.5 131.5%   
Avg. wages/employee Rs Th991.4843.2 117.6%   
Avg. net profit/employee Rs Th819.8792.4 103.4%   
INCOME DATA
Net Sales Rs m23,68658,569 40.4%  
Other income Rs m7082,233 31.7%   
Total revenues Rs m24,39460,802 40.1%   
Gross profit Rs m5,28113,773 38.3%  
Depreciation Rs m1,3133,069 42.8%   
Interest Rs m152,056 0.7%   
Profit before tax Rs m4,66110,881 42.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6911,545 109.4%   
Profit after tax Rs m2,9709,336 31.8%  
Gross profit margin %22.323.5 94.8%  
Effective tax rate %36.314.2 255.5%   
Net profit margin %12.515.9 78.7%  
BALANCE SHEET DATA
Current assets Rs m15,67353,841 29.1%   
Current liabilities Rs m6,67831,612 21.1%   
Net working cap to sales %38.038.0 100.1%  
Current ratio x2.31.7 137.8%  
Inventory Days Days7697 78.2%  
Debtors Days Days2284 26.6%  
Net fixed assets Rs m8,09842,079 19.2%   
Share capital Rs m230846 27.2%   
"Free" reserves Rs m17,08842,655 40.1%   
Net worth Rs m17,35643,501 39.9%   
Long term debt Rs m022,408 0.0%   
Total assets Rs m25,400101,250 25.1%  
Interest coverage x311.76.3 4,953.4%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.90.6 161.2%   
Return on assets %11.811.3 104.5%  
Return on equity %17.121.5 79.7%  
Return on capital %26.919.6 137.3%  
Exports to sales %24.50-   
Imports to sales %28.00-   
Exports (fob) Rs m5,801NA-   
Imports (cif) Rs m6,627NA-   
Fx inflow Rs m7,14520,066 35.6%   
Fx outflow Rs m6,8465,304 129.1%   
Net fx Rs m29914,762 2.0%   
CASH FLOW
From Operations Rs m3,22610,127 31.9%  
From Investments Rs m-1,555-7,869 19.8%  
From Financial Activity Rs m-1,818-1,918 94.8%  
Net Cashflow Rs m-147212 -69.5%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 60.4 0.0 -  
Indian inst/Mut Fund % 14.4 7.0 205.1%  
FIIs % 14.6 12.6 115.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 8.8 119.3%  
Shareholders   15,184 26,511 57.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  PANACEA BIOTECH  CADILA HEALTHCARE  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Power Stocks Top Losers(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jan 19, 2018 03:33 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - NOVARTIS COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS